
Patent Law Weblog
recent posts
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
- Reasons for the PTAB’s Priority Determination in Broad’s Favor (Perhaps)
- Mexico Publishes Amendments to Intellectual Property Law
- PTAB (Again) Awards Priority of Invention to Broad in Interference No. 106,115
- Argentina Repeals Pharmaceutical Patent Examination Guidelines
about
Category: Patent Office Rules & Procedures
-
As reported earlier this month on Patent Docs, the biotechnology, chemical, and pharmaceutical technology groups at the USPTO will hold the next quarterly meeting next Tuesday, December 4, 2007. The Patent Office has posted the official announcement which includes the list of topics and speakers: Morning Session (9:00-noon EST): Greeting and Overview Invention Secrecy Program…
-
By Kevin E. Noonan — Gene Quinn from the PLI blog reports today that Judge Cacheris denied from the bench Plaintiffs’ motion for discovery in the challenge to the claims and continuation rules enjoined by the Court on October 31st (see "Tafas v. Dudas; SmithKline Beecham Corp. v. Dudas (E.D. Va. 2007)"). Patent…
-
A Reason for Thanksgiving By Kevin E. Noonan — Patent law is no longer the backwater it resembled prior to the creation of the Federal Circuit, but it rarely receives the limelight of national attention. Until recently, that is, when it seems every editorial and pundit is weighing in on how "broken" the…
-
By Christopher P. Singer — In a November 9, 2007 press release, the U.S. Patent and Trademark Office announced that the European Patent Office (EPO), the Japan Patent Office (JPO), and the USPTO signed a memorandum of understanding that is designed to address the global workload challenges arising from the growth and complexity…
-
By Donald Zuhn — The U.S. Patent and Trademark Office released its FY 2007 Performance and Accountability Report today and announced that the Office had posted record-breaking numbers for 2007. According to the Patent Office, the year-end numbers "reveal historic improvement in the quality of patent and trademark reviews and subsequently the quality…
-
By Kevin E. Noonan — The following is part of a continuing series on how to address the very real problems facing the U.S. Patent and Trademark Office. A day after the day of rejoicing for inventors, patent practitioners, examiners, and seemingly all of civilization, fair-minded people will concede that the U.S. Patent…
-
By Donald Zuhn — The following is part of a continuing series on how to address the very real problems facing the U.S. Patent and Trademark Office. A day after the day of rejoicing for inventors, patent practitioners, examiners, and seemingly all of civilization, fair-minded people will concede that the U.S. Patent and…
-
The biotechnology, chemical, and pharmaceutical technology groups at the U.S. Patent and Trademark Office are scheduled to hold the next quarterly meeting on December 4, 2007. The proposed topics for discussion include: Morning Session (9:00-noon EST) Patent Corp Security Program — (presenter: Don Hajec, Director, TC3600) KSR Overview, Court Opinion and PTO Guidelines, and Technology…
-
By Kevin E. Noonan — The following is part of a continuing series on how to address the very real problems facing the U.S. Patent and Trademark Office. A day after the day of rejoicing for inventors, patent practitioners, examiners, and seemingly all of civilization, fair-minded people will concede that the U.S. Patent…
-
By Kevin E. Noonan — The following is part of a continuing series on how to address the very real problems facing the U.S. Patent and Trademark Office. A day after the day of rejoicing for inventors, patent practitioners, examiners, and seemingly all of civilization, fair-minded people will concede that the U.S. Patent…